AAPL 237.5 1.809% MSFT 426.24 2.5429% NVDA 135.5501 2.8765% GOOGL 195.37 3.0107% GOOG 196.84 3.0306% AMZN 222.4999 2.1767% META 619.8747 4.3121% AVGO 227.51 1.2506% TSLA 420.01 5.9668% TSM 205.23 1.8764% LLY 746.665 0.2356% V 316.69 2.4588% JPM 252.363 1.9772% UNH 544.335 0.1094% NVO 82.94 2.168% WMT 91.475 0.7545% LVMUY 131.3 -2.0515% XOM 111.354 1.4892% LVMHF 656.0 -1.7131% MA 520.8 2.3143%

BioCryst Pharmaceuticals Inc

Healthcare US BCRX

6.9982USD
-0.2318(3.21%)

Last update at 2025-01-16T14:55:00Z

Day Range

6.987.28
LowHigh

52 Week Range

4.038.88
LowHigh

Fundamentals

  • Previous Close 7.23
  • Market Cap1601.14M
  • Volume268531
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-31.94100M
  • Revenue TTM412.58M
  • Revenue Per Share TTM2.01
  • Gross Profit TTM 10.94M
  • Diluted EPS TTM-0.61

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -244.38400M -181.80900M -182.81400M -108.89700M -101.25200M
Minority interest - - - - -
Net income -247.11700M -184.06200M -196.56700M -120.06500M -101.25200M
Selling general administrative 159.37M 118.82M 67.93M 37.12M 29.51M
Selling and marketing expenses - - - - -
Gross profit 264.23M 149.91M 16.14M 44.73M 20.18M
Reconciled depreciation 1.44M 0.78M 0.75M 0.72M 0.77M
Ebit -148.43500M -177.72000M -174.75700M -99.45500M -92.73800M
Ebitda -143.30800M -177.65800M -165.33700M -97.52200M -91.96800M
Depreciation and amortization 5.13M 0.06M 9.42M 1.93M 0.77M
Non operating income net other - 55.14M -2.97600M 2.45M 2.14M
Operating income -148.43500M -177.72000M -174.75700M -99.45500M -94.22000M
Other operating expenses 419.26M 334.89M 192.57M 148.29M 114.87M
Interest expense 99.09M 59.29M 14.50M 11.89M 9.18M
Tax provision 2.73M 2.25M - - -
Interest income 5.13M 0.06M 9.42M 1.93M 2.25M
Net interest income -93.96500M -59.23200M -5.08100M -9.95900M -6.92400M
Extraordinary items - - - - -
Non recurring - - 0.13M 0.38M 0.47M
Other items - - - - -
Income tax expense 2.73M 2.25M 13.75M 11.17M 2.14M
Total revenue 270.83M 157.17M 17.81M 48.84M 20.65M
Total operating expenses 412.67M 327.63M 190.89M 144.19M 114.40M
Cost of revenue 6.59M 7.26M 1.68M 4.10M 0.47M
Total other income expense net -95.94900M -4.08900M -8.05700M -9.44200M -0.10800M
Discontinued operations - - - - -
Net income from continuing ops -247.11700M -184.06200M -192.23400M -108.89700M -101.25200M
Net income applicable to common shares -247.11600M -184.06200M -182.81400M -108.89700M -101.25200M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 516.96M 550.00M 588.15M 334.71M 175.28M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 19.54M 12.59M 9.99M 5.53M 4.42M
Total liab 972.49M 844.60M 695.14M 353.98M 137.03M
Total stockholder equity -455.52800M -1454.62100M -1207.50400M -1023.44200M -840.62800M
Deferred long term liab